There is research on this stock available only to PRO subscribers.
We currently have no Breaking News on this stock.
PPHM vs. ETF Alternatives
Peregrine Pharmaceuticals Inc is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for treatment & diagnosis of cancer. With its phosphatidylserine-targeting platform, it is pursuing two clinical programs in cancer.
Other News & PR